From Prototype to Profit: Commercialization Insights

Playa Bowls enters the booming refresher market with its new Surf Quenchers, leveraging its superfruit expertise to challenge sugary rivals and fuel its rapid franchise expansion.

With a 'tens of millions' Pre-Series A led by Temasek's GenZero, PCG Global is set to replicate its proven Chinese energy model across key emerging markets.

As Assam reels from devastating floods, Canara HSBC Life Insurance deploys a rapid-response claims process. A look at how this operational pivot tests the true value of a policy.

With a nationwide Whole Foods deal and two CPG titans now on its leadership team, Ancient Crunch is executing a masterclass in scaling a niche snack brand.

Michigan's Oxford Bank posts a strong Q2 rebound driven by niche lending, but rising nonperforming assets and a strategic funding shift reveal a complex path to profit.

A startup's new software smooths the volatile power spikes from AI data centers, promising to cut costs, reduce failure risk, and make AI growth sustainable.

Amid legal battles and policy shifts threatening the $100B 340B drug program, GPOs like HealthTrust are becoming critical navigators for hospital survival.

Appdome's new 'agentic' platform validates protected mobile apps against real-world user devices, aiming to transform DevSecOps and streamline compliance.

Japan's largest bank reports a stunning 48% profit jump, fueled by higher domestic loan margins and its Morgan Stanley stake, beating analyst estimates.

MagIron unveils a multi-billion dollar plan to end U.S. reliance on imported pig iron, a critical step for national security and steel decarbonization.

While global industrial markets waver, refractory leader RHI Magnesita proves strategic self-help can deliver powerful growth. Here's how they're doing it.

Utenos Trikotažas reports a loss, but a closer look reveals a strategic shift with soaring brand sales and export growth in a challenging market.

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.

A landmark study validates Astrin Biosciences' proteomic test, Certitude, boasting >92% accuracy and offering new hope for women with dense breasts.

Sherwin-Williams' 2027 'Rewild' forecast isn't just about new colors; it's a strategic pivot from prescription to intuition, designed to capture the market's demand for personal expression.

A novel partnership between SuperPower and Ever.green is turning gamers into a new class of clean energy investors, funding a 110 MW Texas solar project.

The science firm sees a return to growth, driven by its Materials unit. A strategic review of its Performance & Care segment signals a major shift.

Lōkahi Therapeutics aims to turn 15 injections into one for its pain drug LT-100, a move that could transform patient care and unlock major commercial value.

Novo Resources formalizes a key JV and kicks off a major drilling program at Tibooburra, testing high-grade targets in a region likened to the Victorian Goldfields.

Rokid enters North America with AI-powered smart glasses, aiming to conquer Canada's diverse market with real-time translation and a key optical partnership.